跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tazobak - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tazobak
Approved
STANDARD
Tazobak
Swiss Parenterals Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
53739ab69a42e6d0
Company
Swiss Parenterals Ltd.
Type
Standard
Approval Details
Approval Id
53739ab69a42e6d0
Drug Approval Philippines Name
Tazobak
Product Name
Tazobak
Registration Number
DRP-1307
Brand Name
Tazobak
Generic Name
Piperacillin (as sodium) + Tazobactam (as sodium)
Dosage Form
Powder for Injection (I.V.)
Dosage Strength
4 g/500 mg
Manufacturer
Swiss Parenterals Ltd.
Importer
Endure Medical, Inc.
Distributor
Endure Medical, Inc.
Issuance Date
27 September 2023
Expiry Date
27 September 2028
Pharmacologic Category
Antibacterials (Penicillins)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
53739ab69a42e6d0
Type
Standard
Back to Philippines FDA Approvals